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SConclusions: Complete revascularization after PCI was achieved in less than 50% of
pts with ACS, and was less frequent in DM compared to non-DM pts. Patients with
DM had higher rates of adverse outcomes compared to non-diabetics even when CR
was achieved, and the extent of IR was less of a prognostic factor in DM compared to
non-DM pts. Further strategies are required to improve the prognosis in high-risk
DM pts.
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Higher Adverse Clinical Event Rates in Young African American Women
Undergoing Percutaneous Coronary Intervention: Results from the NHLBI
Dynamic Registry
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Background: Prior studies suggest that younger women are at higher risk for major
adverse events following PCI; however, little is known about the association between
race and adverse outcomes in this population.
Methods: We evaluated 3797 women undergoing PCI in the NHLBI Dynamic
Registry and compared 1 year outcomes in African American (AA) women <50 years
(n¼101), AA women  50 years (n¼537), non-AA women < 50 years (n¼293), and
non-AA women  50 years (n¼2866) old.
Results: AA women were more likely to have hypertension, renal disease, and
concomitant severe non-cardiac disease compared to non-AA women. Irrespective of
race, younger women had less severe CAD angiographically. In-hospital adverse
events (death, MI, CABG, stroke) were comparable by race and age; however, young
AA women had the highest rate of MACE (young AA women: 28.6%, older AA
women: 18.4%, young non-AA women 27.6%, older non-AA women: 23.3%,
p¼0.02) at 1 year. While the rate of MI was lower (young AA women: 3.6%, older
AA women: 5.8%, young non-AA women 7.2%, older non-AA women: 5.4%,
p¼0.50), young AA women had a higher incidence of mortality than non-AA women
of similar age (young AA women: 5.8%, older AA women: 5.0%, young non-AA
women: 1.1%, older non-AA women: 5.8%, p¼0.009) at 1 year. Young women also
had higher rates of repeat revascularizations compared to older women, with young
AA women having the highest rate of CABG and young non-AA women having the
highest rate of repeat PCI at 1 year.One-Year Cumulative Event Rates for Women, By Race and Age
Follow-up
Events
(N=3797)
African
American
Age < 50
(N=101)
African
American
Age  50
(N=537)
Non-
African
American
Age <
50(N=293)
Non-African
American
Age 
50(N=2866)
p value
(comparing
all 4
groups)
% % % %
MACE1 28.6 18.4 27.6 23.3 0.03
Death 5.8 5.0 1.1 5.9 0.009
Myocardial
Infarction
3.6 5.8 7.2 5.4 0.50
Death or
Myocardial
Infarction
9.2 10.3 7.9 10.6 0.52
CABG 10.5 3.8 8.4 4.9 0.005
Repeat
PCI2
16.2 9.6 19.9 12.5 <0.001
CABG/
Repeat
PCI2
24.2 11.9 25.0 16.4 <0.001
Abbreviations MACE-major adverse cardiovascular events, CABG - coronary artery bypass graft
surgery, PCI - percutaneous coronary intervention
1Composite of death/myocardial infarction/CABG/repeat PCI
2 Excluding planned, staged PCI
JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrConclusions: Young AA women experienced higher rates of major adverse events
within 1 year of PCI, including a mortality rate four times higher than non-AA women
of similar age. It is plausible that our ﬁndings are due to a higher prevalence of non-
cardiac comorbidities; however, secondary prevention measures and practice patterns
post-PCI need to be explored to ensure this population is receiving optimal cardio-
vascular care following PCI.
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Survival after percutaneous coronary intervention (PCI): Comparison of patients
with or without Left Anterior Descending stenosis in elective percutaneous
coronary intervention for left main disease and triple vessel disease
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Thomas G. Nuehrenberg1, Christian M. Valina1
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Background: Patients with signiﬁcant left anterior descending artery (LAD) disease,
particularly when the proximal segment is involved, considered to have an adverse
cardiac prognosis. It is reported that proximal LAD stenosis (P-LAD) have higher
rates of restenosis than that in other coronary segments after angioplasty, as well as
after stenting. However, the long term results of patients with P-LAD in complex
coronary artery disease (CAD) have not yet been adequately studied. Our study aimed
to ﬁnd out if the long term mortality of patients with P-LAD among the cohort with
three vessel diseases (TVD) and/or left main stenosis (LMS) higher than that without
P-LAD.
Methods: Patients undergoing elective PCI with drug eluting stents (DES) for TVD
and/or LMS have been included in this study. Important exclusion criteria were
previous coronary artery bypass surgery, high-risk acute coronary syndrome including
myocardial infarction. All-cause death was the primary endpoint of this analysis.
Survival of the patients was assessed by systematic patient contacts at one, two and
three years. In all patients we calculated SYNTAX score (SSc) to deﬁne the anatomic
complexity of coronary artery disease and logistic EuroScore (LES) to determine the
clinical risk. We used the Kaplan-Meier method to estimate the mortality. In addition,
we calculated adjusted and unadjusted hazard ratios by Cox models.
Results: 1,262 patients (mean age 67.7310.33 years, 24% female, median SSc
21.348.47) met the entry criteria. Median follow-up was 1197465.05 days. P-LAD
was present in 364 patients (28.84%). SSc in group with P-LAD was higher
(24.698.24 vs. 208.36, p<0.01). There was no signiﬁcant difference of one, two
and three-year mortality between the group with and without P-LAD (3.00.9 % vs.
2.90.6%; 5.01.2% vs. 5.20.7; 8.01.5% vs. 8.21.0%, p¼0.67; 0.64; 0.69).
Hazard ratio for mortality in the presence of P-LAD was 1.08 (95% CI 0.76 – 1.54,
p¼0.67). Even after adjustment for SSc and LES in multivariable analysis, P-LAD
was not predictive for mortality (adjusted HR 1.34 (0.94 – 1.94), p¼0.11).
Conclusions: P-LAD as single criterion has no signiﬁcant prognostic relevance in
patients with complex CAD.
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Patients with Intermediate and High SYNTAX when Demographic and Clinical
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Background: Randomized controlled trials in patients with complex ischemic heart
disease (CIHD) suggest that patients with an intermediate/high SYNTAX score
beneﬁt from surgical revascularization. However its impact in decision making in
routine clinical practice is unknown. Using a multidisciplinary Heart Team (MHT) we
set out to evaluate therapeutic decision making in patients with complex IHD using
SYNTAX scores combined with Society of Thoracic Surgeons (STS)-derived clinical
variables.
Methods: MHT meetings consisting of interventional cardiologists and cardiac
surgeons were convened to discuss management of patients with CIHD. Angiographic
SYNTAX and STS risk were calculated and grouped according to risk scores Figure 1.
Final recommendations on revascularization were based on consensus that factored
angiographic and clinical characteristics
Results: 201 consecutive patients underwent MHT review. Mean(SD) STS risk
between groups showed; Group 1:1.4%(1.02), Group 2:7.4%(1.8), Group 3:1.5%(1.2)
and Group 4:9.9%(4.8) (p<0.0001). Mean(SD) SYNTAX score showed; group
1:15(4.8), Group 2:16(4.7), Group 3:29.7(6.1), and Group 4:32.4(6.1) (p<0.0001).
MHT recommendations are outlined in Tableacts/POSTER/Miscellaneous Coronary Topics B103
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decision-making in routine practice. A MHT approach resulted in recommendation for
surgical revascularization in patients with low-STS risk regardless of SYNTAX score.
Conversely, PCI was recommended more frequently in patients with high STS-risk
regardless of SYNTAX. Further studies should focus on the clinical outcomes of these
revascularization strategies.
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In-Hospital and Long-Term Prognosis of Anemia on Admission in Patients
Undergoing Percutaneous Coronary Intervention
Ester Canovas Rodriguez1, Lorenzo Hernando Marrupe2, Alfonso Freites Esteves1,
Pablo Salinas1, Roberto Del Castillo Medina1, Adriana De la Rosa Riestra2,
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MADRID, Spain
Background: Anemia is common before percutaneous coronary intervention (PCI).
Numerous studies have shown the prognostic value of anemia in patients with acute
coronary syndrome (ACS). Nevertheless, few studies have investigated the long-term
impact and in-hospital prognosis of anemia on admission in patients undergoing PCI
and constitutes the aim of this study.
Methods: We performed a single-center observational study with prospective follow-
up of 759 consecutive patients undergoing PCI between 2007 and 2011. Anemia was
deﬁned according to OMS’s criteria (hemoglobin <13 g /dl in men and <12 g /dl in
women). We evaluated the relationship between anemia on admission with cardio-
vascular events and long-term mortality (mean follow-up 26.5  14.4 months).
Results: Anemia on admission was observed in 226 (23.5%) patients. Patients with
anemia on admission were older (72  10 vs. 64  11 years, p <0.001), female
(23.5 vs. 15.2%, p ¼ 0.006) diabetic (47.3 vs. 31.5%, p <0.001) and hypertense
(76.1 vs. 63.4%, p ¼ 0.001). Most often patients were previously treated with anti-
coagulants (14.2 vs. 7.3%, p ¼ 0.003) antiplatelets (58.4 vs. 44.1%, p <0.001) had
increased prevalence of acute myocardial infarction (AMI) on admission (59.7 vs.
49.2%, p ¼ 0.008), lower creatinine clearance (66.5  29.6 78.9  23 ml/min/
1.73m2, p <0.001) and higher levels of C reactive protein (35.5  54.5 front 13.2 
25.6 mg/l, p <0.001). While being hospitalized patients had a higher incidence of
contrast-induced acute kidney injury (15 vs. 6%, p <0.001), bleeding complications
(19.5 vs. 8.6%, p <0.001), need for transfusion (6.6 vs. 6%, p <0.001) and mortality
(5.3 vs. 1.5%, p ¼ 0.003). During long-term follow-up they had more readmissions
(59.7 vs. 47.7%, p ¼ 0.002), AMI with ST segment elevation (4.5 vs. 1.7%, p ¼
0.027), stroke (5.8 vs. 2.1%, p ¼ 0.008) cardiac mortality (8 vs. 2.8%, p <0.001) and
all cause mortality (20.4 vs. 4.9%, p <0.001). Cox regression analysis showed that
anemia was an independent predictor of all cause mortality (adjusted hazard ratio ¼
2.1, CI 95% 1.1-4.1, P ¼ 0.028)
Conclusions: Patients with anemia on admission are numerous and have both poorer
in hospital and long term prognosis and increased long-term mortality.
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Late lumen enlargement - a potential new paradigm in vascular therapy
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Background: Local paclitaxel delivery to coronary arteries by application of a drug-
coated balloon (DCB) has been shown to reduce in-stent restenosis (ISR) and lateB104 JACC Vol 62/18/Suppl B j October 27–Novemlumen loss in de novo lesions of small coronary arteries in comparison to other forms
of PCI. While inherent healing processes after plane PTCA have led to a high rate of
restenosis due to recoil and intimal proliferation, we observed an unanticipated
decrease in residual stenosis while following patients after application of DCBs. It was
the aim of this study to systematically study and quantify this phenomenon.
Methods: We evaluated 58 native coronary artery lesions mainly of small vessels (12
RCA, 21 LAD and 25 CX) in 56 consecutive patients directly after DCB intervention
and 42 months thereafter by quantitative coronary angiography. Treatment of ISR
and left main lesions was excluded from this analysis. Mean vessel reference diameter
was 2.590.45 mm and initial stenosis grade was 69.114.0%. To exclude a vaso-
motor tone effect a non-target vessel was evaluated as to the diameter change within
the observation period and from identical cine frames (n¼43). All PCIs were tech-
nically performed according to the recommendations of the German Consensus
Group.
Results: Minimal and mean lumina of the lesion and the treated segment increased
highly signiﬁcantly. The late lumen increase of the target lesion within the observation
period was 0.16 mm (1.750.58 vs 1.910.55 mm, p<0.05) and the diameter
stenosis was further reduced from 33.812.3 at end of index procedure to 26.913.8
% (p<0.05) at follow up angiography, while there were no changes in the vessel
diameter of the non target reference vessel (2.330.60 vs 2.340.61 mm, p ¼ n.s.).
No reintervention occurred in any of these patients, and MACE rate was 1.8%. There
was only 1 binary restenosis.
Conclusions: Local application of paclitaxel by drug-coated balloons to native
coronary arteries leads to late lumen enlargement in contrary to all other forms of PCI,
which all lead to LLL.
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Clinical Outcomes Based Upon Classiﬁcation Using Appropriateness Use
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A. J. Conrad Smith4, John T. Schindler1, Sun K. Scolieri2, Suresh Mulukutla1
1University of Pittsburgh, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA,
3University of Pittsburgh, Pittsburgh, PA, 4University of Pittsburgh, Pittsburgh, USA
Background: The classiﬁcation of patients using the appropriate use criteria (AUC)
for percutaneous coronary intervention (PCI) is growing, however the AUC are
criticized due to systematic and methodological issues. It is unclear to what extent
clinical outcomes may change based upon procedures classiﬁed as appropriate,
uncertain, or inappropriate.
Methods: Consecutive patients without acute coronary syndrome undergoing PCI at
multiple hospitals across the University of Pittsburgh Health System were enrolled in
a registry and followed prospectively since October 2011. Patient characteristics, in-
hospital events, and 6 month follow up were recorded. Using national guidelines,
cases were classiﬁed by the AUC criteria.
Results: A total of 442 cases were evaluated, among which 56.3% were Appropriate,
25.8% Uncertain, and 17.9% Inappropriate. There were no signiﬁcant differences with
regard to cardiovascular risk factors, except that patients classiﬁed as Appropriate
were more likely to have a prior history of myocardial infarction or bypass surgery.
Patients classiﬁed as Inappropriate were signiﬁcantly more likely to not have prior
stress testing (20.5% Appropriate vs. 53.2% Inappropriate, p<0.0001) and were more
likely to be asymptomatic. Cases classiﬁed as Inappropriate were signiﬁcantly more
likely to be pre-operative cases prior to non-cardiac surgery (9.6% Appropriate vs.
29.1% Inappropriate, p<0.0001). There were no differences in lesion and procedural
characteristics or signiﬁcant differences in the 6-month outcomes of death, myocardial
infarction, bleeding, in-stent thrombosis, or hospital readmission.
Conclusions: There are important characteristics of “Inappropriate” procedures that
may drive interventional cardiologists to perform these procedures; however, the AUC
do not allow for some factors to be considered in determining appropriateness. There
were no signiﬁcant differences in outcomes based upon AUC classiﬁcation. The AUC
criteria can be valuable but are limited and need to be reﬁned to incorporate important
factors that are often considered in routine clinical practice in the care of patients with
coronary artery disease.
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Cardiovascular Imaging Radiation in Coronary Artery Disease: Is It a Real
Concern?
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Background: The number of cardiac diagnostic and therapeutic procedures involving
ionizing radiation has increased rapidly in recent years, raising concerns about patients
(pts) radiation exposure. The annual pts effective radiation dose (ED) should not
exceed 1mSv, which is equivalent to 50 chest X-rays. We intend to estimate ED due to
cardiac diagnosis and therapeutic exams in pts with chronic coronary artery dis-
ease(CAD) during follow-up.
Methods: CAD outpatients of a tertiary hospital who had at least one cardiovascular
image exam were selected from 1999 to 2011. Patient evaluation of ED was
accomplished through literature standard values and multiplied by the number of testsber 1, 2013 j TCT Abstracts/POSTER/Miscellaneous Coronary Topics
